Aptorum Group Limited (APM)
NASDAQ: APM · Real-Time Price · USD
0.8690
+0.0290 (3.45%)
May 5, 2026, 4:00 PM EDT - Market closed
Aptorum Group Market Cap
Aptorum Group has a market cap or net worth of $7.08 million as of May 6, 2026. Its market cap has increased by 19.17% in one year.
Market Cap
7.08M
Enterprise Value
7.07M
1-Year Change
19.17%
Ranking
Category
Stock Price
$0.87
Market Cap Chart
Since December 18, 2018, Aptorum Group's market cap has decreased from $415.79M to $7.08M, a decrease of -98.30%. That is a compound annual growth rate of -42.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 4, 2026 | 6.84M | -20.75% |
| Dec 31, 2025 | 8.63M | -45.03% |
| Dec 31, 2024 | 15.70M | 23.78% |
| Dec 29, 2023 | 12.69M | -35.41% |
| Dec 30, 2022 | 19.64M | -63.24% |
| Dec 31, 2021 | 53.44M | -36.39% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 18, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Addex Therapeutics | 7.39M |
| TransCode Therapeutics | 7.31M |
| Moolec Science | 7.30M |
| FibroBiologics | 7.19M |
| Processa Pharmaceuticals | 7.14M |
| Akari Therapeutics, | 6.90M |
| Immuron | 6.84M |
| Enveric Biosciences | 6.77M |